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Abstract
Introduction:  The management of bloodstream infec-
tions especially sepsis is a difficult task. an optimal an-
tibiotic therapy (abX) is paramount for success. Pro-
calcitonin (PCT) is a well investigated biomarker that
allows close monitoring of the infection and manage-
ment of abX. It has proven to be a cost-efficient diag-
nostic tool. In diagnoses Related groups (dRg) based
reimbursement  systems,  hospitals  get  only  a  fixed
amount of money for certain treatments. Thus it’s very
important to obtain an optimal balance of clinical treat-
ment and resource consumption namely the length of
stay in hospital and especially in the Intensive Care Unit
(ICU). We investigated which economic effects an opti-
mized PCT-based algorithm for antibiotic management
could have.
Materials and Methods: We collected inpatient episode
data from 16 hospitals. These data contain administra-
tive and clinical information such as length of stay, days
in the ICU or diagnoses and procedures. from various
RCTs and reviews there are different algorithms for the
use  of  PCT  to  manage  abX  published.  Moreover
RCTs and meta-analyses have proven possible savings
in  days  of  abX  (abd)  and  length  of  stay  in  ICU
(ICUd). as the meta-analyses use studies on different
patient populations (pneumonia, sepsis, other bacterial
infections), we undertook a short meta-analyses of 6
relevant studies investigating in sepsis or ventilator as-
sociated pneumonia (vaP). from this analyses we ob-
tained  savings  in  abd  and  ICUd  by  calculating  the
weighted  mean  differences.  Then  we  designed  a  new
PCT-based algorithm using results from two very re-
cent  reviews.  The  algorithm  contains  evidence  from
several studies. from the patient data we calculated cost
estimates using german national standard costing in-
formation for the german g-dRg system.
We developed a simulation model where the possible
savings and the extra costs for (in average) 8 PCT tests
due to our algorithm were brought into equation.  
Results: We  calculated  abd  savings  of  -4  days  and
ICUd reductions of -1.8 days. our algorithm contains
recommendations for abX onset (PCT ≥ 0.5 ng/ml),
validation  whether  abX  is  appropriate  or  not  (delta
from  day  2  to  day  3  ≥  30%  indicates  inappropriate
abX)  and  recommendations  for  discontinuing  abX
(PCT ≤ 0.25 ng/ml).
We received 278,264 episode datasets where we iden-
tified  by  computer-based  selection  3,263  cases  with
sepsis. after excluding cases with length of stay (los)
too  short  to  achieve  the  intended  savings,  we  ended
with  1,312  cases  with  ICUd  and  268  cases  without
ICUd. average length of stay of ICU-patients was 27.7
ﾱ 25.7 days and for non-ICU patients 17.5 ﾱ 14.6 days
respectively. ICU patients had an average of 8.8 ﾱ 8.7
ICUd. 
after applying the simulation model on this popula-
tion we calculated possible savings of € -1,163,000 for
ICU-patients and € -36,512 for non-ICU patients. 
Discussion: our findings concerning the savings from
the reduction of abd are consistent with other publi-
cations. savings ICUd had never been economically
evaluated so far. our algorithm is able to possibly set a
new standard in PCT-based abX. However the find-
ings are based on data modelling. The algorithm will
be implemented in 5-10 hospitals in 2012 and effects
in clinical reality measured 6 months after implemen-
tation.
Conclusion:  Managing sepsis with daily monitoring of
PCT using our refined algorithm is suitable to save sub-
stantial  costs  in  hospitals.  Implementation  in  clinical
routine settings will show how much of the calculated
effect will be achieved in reality.
Abbreviations
abd days of antibiotic treatment
abX antibiotic Therapy
alos average length of stay in a given dRg, basis
for  determining  whether  a  patient  causes
more costs than reimbursement
CW cost-weight of a given dRg, directly related
to  clinical  and  economical  “severity”  (re-
source consumption)
dRg diagnoses related groups, systems to classify
patients based on their resource consump-
tions
HMv Hours of mechanical ventilation
ICd International Classification of diseases
ICd-10 ICd, Revision 10
ICU Intensive care unit
ICUd treatment days on an intensive care unit
los length of stay in hospital
nlos length of stay on normal ward;
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InTRodUCTIon
sepsis is a severe disease with poor clinical as econom-
ical  outcomes  and  a  high  mortality  [1-3].  Moreover
sepsis treatment does often not adhere to practice rec-
ommendations [4].
PCT is a well proven test for detection of bacterial
infections and to determine start and end of antibiotic
therapy  in  various  settings  [5-9].  Using  PCT-based 
algorithms  to  monitor  and  manage  antibiotic  treat-
ment saves abd and ICUd as well as cost for antibi-
otics (by the effect of allowing an early de-escalation
strategy). This has been proven in PCT-related RCTs
and verified in meta-analyses and reviews [7, 8, 10, 11].
The cost-efficiency of using PCT to reduce cost of
antibiotic treatment was also shown [12, 13].
In germany hospitals are reimbursed by diagnoses
Related groups (dRg) determined payments. due to
the  nature  of  dRg-based  reimbursement  systems
clinical and economical optimization should focus on
the  reduction  of  los  especially  ICUd  [14,  15].  In
many hospitals cost-saving efforts are centered on sin-
gle areas like medication cost, cutting staff expenses
or other without calculating the effects on the com-
plete treatment process.
However, so far no publications are available which
investigate the economic effect of the possible savings
by using PCT-based treatment algorithms in a dRg-
reimbursement setting.
We conducted a study to determine possible savings
in medication costs and costs for ICU-treatment using
dRg  data  and  favourable  effects  of  a  PCT-based
treatment algorithm in sepsis patients.
MaTERIals and METHods
We retrieved patient level dRg routine data from 16
hospitals  in  germany.  all  patients  were  treated  in
2010.  The  german  national  minimal  basic  datasets
(Mdbs)  contains  episode  data  (admission  and  dis-
charge date, ICUd) and diagnoses (one PdX and up
to 50 sdX). 
ICUd are reported if the patient is treated in a spe-
cialised intensive-care unit. from previous data analy-
ses we know that there exists an amount of patients
treated in intermediate care units.
We developed an algorithm to detect sepsis patients
by  using  the  various  ICd-10  codes  and  examining
PdX and sdX of all patients. once a sepsis code oc-
curred the patients were flagged as ‘sepsis present’. by
using the ICUd provided from the hospitals we fur-
ther  determined  whether  the  patient  was  treated  on
ICU  or  not.  If  so,  we  flagged  the  patients  as  ‘ICU
treated’. Patients being on intermediate care units or
small intensive care units without ICUd being present
in the dataset we flagged as ‘non-ICU’. 
Existing reviews on PCT are often based on RCTs
with varying sample structures without considering in-
fluences of the different sample structures. although
favourable outcomes are proven, we decided to calcu-
late possible positive effects of a PCT-based algorithm
by pooling data from RCTs which mainly deal with
sepsis patients or at least had sepsis patient or blood-
stream infections as subgroups. as ICUd and abd
are continuous variables we calculated weighted means
according to the recommendations in the QUoRoM
statement [16].
Using  the  results  from  a  recent  review  on  PCT-
based  algorithms  for  the  management  of  infections
[7],  we  calculated  an  average  utilization  of  7  subse-
quent PCT-tests. The average cost for a PCT-test in
germany  is  €  25  (based  on  data  from  the  vendor).
This  would  reflect  the  application  of  an  algorithm
based on daily testing.
by using the german national costing manual, we
estimated treatment costs for each patient as the hos-
pitals did not deliver data from the german national
Cost data collection. The Institute for the reimburse-
ment system in hospitals – InEK provides national av-
erage  costs  for  each  german  dRg.  However  these
costs are strongly related to the los in hospitals and
to the ICUd. Therefore we calculated costs for the pa-
tients  by  calculating  the  following  cost  proportions
from the national average costs:
• ICU costs: the german average costs for one day of
ICU treatment is app. € 1,100 [3]. ICUd were mul-
tiplied with these costs
• los-related costs: Treatment on the regular ward
(including intermediate care), the use of diagnostic
departments  and  medication  costs  show  a  strong
correlation to the los. We calculated a nlos by
subtracting the ICUd from the los. nlos was
multiplied with the los-related costs
• Therapy  related  costs:  Each  dRg  contains  costs
for the main therapy in hospital like surgery or car-
diologic  interventions  or  anaesthesia.  These  costs
were directly taken from the national cost averages
for each dRg
Thus  we  were  able  to  estimate  patient  individual
costs dependent on the individual los and ICUd. 
To calculate savings from applying the PCT-based
algorithm on our populations we used the following
assumptions:
• ICUd according to the pooled analyses can only be
saved, if ICUd of the individual patient is at least
one day longer than the estimated savings. Thus we
avoided implausible results if patients had e.g. only
one ICUd. as medication costs (including antibi-
otics)  are  already  part  of  the  cost  calculation  for
one day of ICU treatment, we did not reduce med-
ication costs in patients with ICUd present
• for all patients without ICUd present, we only cal-
culated savings from shorter abd. as data on inter-
mediate care stays were not available, we chose this
conservative approach in order to avoid overestima-
tion of possible savings. Costs for antibiotic treat-
ment in sepsis vary [3, 7, 13]. We chose to build a
flexible  range  for  these  costs  in  our  simulation
model with average daily costs of € 66
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tients  detected  as  ‘sepsis’  patients  in  the  following
(simplified) equation:
Cost (PCT-based algorithm) = original costs – costs
respecting savings + costs for additional PCT-testing.
PCT-tests  are  already  performed  in  most  of  the
hospitals in this study but the utilization of the results
in  terms  of  making  treatment  decisions  is  low  [4].
Therefore we decided not to take the current cost in
account. This is – again – a conservative estimate, as
hospitals that will start using an optimized treatment
algorithm will most likely not produce costs of 7 ex-
tra tests but only the incremental average increase.
REsUlTs
We  collected  data  from  several  RCTs  to  determine
possible  favourable  effects  of  PCT  [9,  17-21].  The
studies had the following results as shown in Table 1.
We included 6 studies. from the boudma publica-
tion of the PRoRaTa trial we extracted the results
from sepsis patients as the trial contained several dif-
ferent  infections.  The  publication  from  stolz  was
based on ventilator-associated pneumonia. However a
number of patients suffered from septic shock and/or
bacteraemia. Moreover vaP is a severe bacterial infec-
tion on the ICU.
by pooling the results and calculated the weighted
means  as  well  as  the  weighted  mean  difference
(WMd) of all trials we found the following results as
basis for our simulation model (Table 2).
for the further calculation we used possible reduc-
tion in abd of -4 days and a possible reduction in
ICUd of -1.8 days.
The weighted mean for days of antibiotic therapy
(abd) was 7.3 in the pooled PCT-groups. Therefore
we took the assumption that 8 PCT-test will be a real-
istic frequency. We developed an algorithm based on
recent reviews and publications on PCT in sepsis pa-
tients [7, 13]. The findings from Charles et.al. strongly
recommend  daily  PCT-testing  as  the  delta  between
day 2 and day 3 shows a significant correlation to ade-
quate versus inadequate abX [5]. figure 1 shows our
recommended algorithm.
We  received  278,264  datasets.  In  3,263  episodes
sepsis was detected and the cases were included in our
analysis. 2,968 cases had at least one day of ICU stay
(Range: 1-32). 1,312 cases had at least 3 ICUd and
were included in the calculation of the savings in the
ICU. 268 out of 295 non-ICU cases had a total los
that was at least 6 days and therefore the possible sav-
ings of 4 abd were applied.
The figure 2 gives an overview of the patient selec-
tion. Table 3 shows the overall financial results after
applying the simulation model.
Introducing the suggested algorithm for PCT-based
abX saves € 1,199,512 in our sample population. as
ICU-costs  are  tremendous,  the  savings  achieved  by
shortening  ICUd  outweigh  the  savings  achieved
through reduction of abd. However, even abd-re-
duction covers the extra-costs for daily PCT-testing.
as most hospitals in our sample do already measure
PCT  but  not  following  strict  algorithms  the  savings
are even higher because we assumed all 8 PCT-tests
will cause extra cost.
In average € 886.4 can be saved, when patients need
intensive care and € 136.2 can be saved per case when
patients are non-ICU. 
dIsCUssIon
We found that our results about reduction of abX-
costs are consistent with the results in other studies.
Heyland  et.al.  assumed  a  reduction  of  2  abd  with
avg. daily abX-costs of Can$148.26 using a regimen
of avg. 6 PCT-test which cost Can$49.42 [13]. all oth-
er  published  results  did  not  explicitly  refer  to  abX
costs but to the reduction of abd. a reduction of
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Table 1.
author Year Patient population Cases  Cases  abd  abd  ICUd  ICUd 
PCT Control PCT Control PCT Control
nobre et.al. 2008 sepsis 31 37 6 10 35
Hochreiter 2009 sIRs 57 53 5.9 7.9 15.5 17.7
bouadma 2010 various, only sepsis used! 55 53 9.8 12.8 n.a. n.a.
svoboda 2007 postoperative sepsis 38 34 n.a. n.a. 16.1 19.4
stolz 2009 vaP (sepsis included) 51 50 7 15 n.a. n.a.
schroeder 2009 surgical sepsis patients 14 13 6.6 8.3 n.a. n.a.
Table 2.
abd (5 studies) ICUd (3 studies)
abd PCT abd Control  ICUd PCT ICUd Control
Weighted Mean (days) 7.3 11.3 12.6 14.4
WMd (days) -4.0 -1.8
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the cost per day are much higher than the costs for
PCT-testing. However in the real life a cost reduction
may only occur in terms of variable costs, because if
less ICUd are needed to treat sepsis patients when ap-
plying the PCT-based algorithm, the fixed costs in the
ICU remain untouched. on the other hand in most
german ICUs there’s a constant shortage of available
beds and various strategies are carried out to meet the
demand [22-24]. Therefore the full daily ICU costs can
be taken in account assuming that the bed is used by a
new patient and a constant utilization of the ICU is
maintained  even  if  the  optimized  therapy  strategies
lead to shorter ICUd in sepsis.
The results shown in this study are based on predic-
tive modelling. We already remarked that modelling is
only part of the story [15]. from our point of view
each model has to be proven in clinical reality. Know-
ing  the  obstacles  as  low  adaption  rate  of  practice
guidelines [4], this is a challenging task. We plan to im-
plement the algorithm described in this paper in 5-10
hospitals in 2012 and measure the effects on ICUd
and abd in the clinical reality.
ConClUsIon
by  using  a  standardized  algorithm  for  PCT-guided
abX-Therapy and assuming that the effects of abd
and ICUd derived from former studies will apply to
the  selected  patient  population  the  use  of  PCT  is
highly cost-effective!
abd and ICUd reductions results in savings of up
to € 1,199,512 or € 886.4 in average for ICU-patients
and € 136.2 for non-ICU patients. 
as shown in many other trials the clinical outcome
is not negatively affected if abX is shortened using
PCT-based algorithms. 
The model we developed will be used for further
investigations. after implementation in clinical reality
direct measurement of the effects will be possible.
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